newsfilter
← Latest News
GlobeNewswire·

Eton Pharmaceuticals Reports First Quarter 2026 Financial Results

Q1 2026 product sales of $24.3 million, representing 73% growth over Q1 2025Raising full year revenue guidance - now expect 2026 revenue to exceed $120 million, up from previous guidance of $110 millionQ1 2026 fully